Insider · CIK 0001765274

Branning Todd P.

Reports to the SEC for 3 companies · BRIDGEWATER, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001765274

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-16	NeuBase Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+54.2K sh	—	—	84,200
2022-11-03	NeuBase Therapeutics, Inc.Stock option (right to buy)A Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2022-03-18	NeuBase Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.81	+$18.1K	30,000
2022-03-17	NeuBase Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.74	+$17.4K	20,000
2022-03-16	NeuBase Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$1.62	+$16.2K	10,000
2022-01-10	NeuBase Therapeutics, Inc.Employee stock option (right to buy)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2021-01-28	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2020-07-13	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+85K sh	—	—	85,000
2020-02-27	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	SVP and CFO	AAward	+83.1K sh	—	—	83,113
2020-02-27	AMRXAmneal Pharmaceuticals, Inc. · Performance-Based Restricted Stock UnitsA Award	SVP and CFO	AAward	+166K sh	—	—	166,226
2020-01-22	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−20.1K sh	—	—	60,290
2020-01-22	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	SVP and CFO	MExercise/Conversion	+20.1K sh	—	—	20,096
2020-01-22	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	SVP and CFO	FTax Payment	−7,311 sh	$5.13	−$37.5K	12,785
2019-11-13	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	SVP and CFO	AAward	+164K sh	—	—	163,666
2019-11-13	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionD Disposition to Issuer	SVP and CFO	DDisposition to Issuer	−164K sh	—	—	0
2019-01-22	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	SVP and CFO	AAward	+164K sh	—	—	163,666
2019-01-22	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	SVP and CFO	AAward	+80.4K sh	—	—	80,386

Recent filings

Accepted (ET)
Mar 174
Branning Todd P.0001104659-23-033858
SEC(opens sec.gov)
Nov 44
Branning Todd P.0001104659-22-114954
SEC(opens sec.gov)
Mar 214
Branning Todd P.0001104659-22-036105
SEC(opens sec.gov)
Mar 184
Branning Todd P.0001104659-22-035572
SEC(opens sec.gov)
Jan 104
Branning Todd P.0001104659-22-002844
SEC(opens sec.gov)
Jan 294
Branning Todd P.0001209191-21-006095
SEC(opens sec.gov)
Jul 134
Branning Todd P.0001209191-20-042292
SEC(opens sec.gov)
Mar 24
Branning Todd P.0000899243-20-006627
SEC(opens sec.gov)
Jan 234
Branning Todd P.0001209191-20-004719
SEC(opens sec.gov)
Nov 144
Branning Todd P.0001723128-19-000127
SEC(opens sec.gov)
Jan 244
Branning Todd P.0001723128-19-000019
SEC(opens sec.gov)

Companies

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807